Neurocytic neoplasms are uncommon and can pose a diagnostic challenge because of overlap of clinical, radiologic, and histologic features with those of other primary brain tumors, particularly oligodendroglioma. 2, 7, 8, 11, 12 Most neurocytomas arise within the lateral ventricles near the foramen of Monro. Thus situated, they represent a distinct clinicopathologic entity, "central neurocytoma." 11, 12 Such lesions are generally low grade, well circumscribed, and curable by resection alone. 9, 12, 16, 19, 27 So-called "atypical neurocytomas," featuring increased proliferative activity and/or microvascular hyperplasia, are associated with an increased risk of recurrence. 1, 5, 6, 15, 21, 31, 33 Neurocytic neoplasms also occur within brain parenchyma without any apparent association with the ventricular system or at intraventricular sites remote from the foramen of Monro. 10, 17, 18, 20, 23, 29, 30, 37, 38 Extraventricular neurocytomas (EVNs) have not been characterized as thoroughly as their intraventricular or "central" counterparts. Specifically, the relation between extent of surgery and histologic features versus clinical outcome has not been systematically explored. Although case reports and small series have suggested histologic differences between central neurocytomas and EVN, it is unclear whether these differences are reflected in biologic behavior. 10, 17, 23, 37 The present study describes the clinical, radiographic, and histopathologic features of 35 cases of EVN to define their morphologic spectrum, response to therapy, and the degree to which histopathologic features affect biologic behavior.
MATERIALS AND METHODS

Clinical Data
Thirty-five EVNs were reviewed from the consultation and institutional services of Johns Hopkins Hospital, Mayo Clinic, and Emory University Hospital from the years 1992-2000. None of the cases has been previously reported. Data regarding clinical presentation, neurora-diologic appearance, operative findings, adjuvant therapy, and follow-up were obtained through patient records and/or the referring institution's Tumor Registry. Only neurocytic neoplasms that appeared to arise within brain parenchyma were studied. Lesions that extended into the surrounding brain from an intraventricular source were excluded. Extent of resection was defined as biopsy, subtotal resection (STR), or gross total resection (GTR) based on information coded in the Tumor Registry at the treating institution.
Histology
All 35 tumors represented surgical specimens. Formalin-fixed, routinely processed, and cut at 4 m, the sections were stained by the hematoxylin and eosin (H&E) method. The diagnosis was based on the histologic and immunohistochemical features previously described for central neurocytoma and other neurocytic neoplasms. 2, 8, 12, 39, 42 The dominant neoplastic component was neurocytic, consisting of a monotonous cell population with round regular nuclei, a finely fibrillar stroma (neuropil), and strong synaptophysin immunoreactivity. Neuronal maturation was frequent (66%). Tumors with histologic evidence of astrocytic differentiation (i.e., mixed neurocytic-astrocytic neoplasms or gangliogliomas) were excluded from study.
Tumors were assessed histologically for general architectural pattern, cellularity, presence of ganglion cells, calcification, parenchymal infiltration, vascular proliferation, and necrosis. Mitotic counts were performed in triplicate and expressed as a mean count per 10 high power fields (HPF).
Immunohistochemisty
Microsections were deparaffinized and subjected to antigen retrieval by either limited protein digestion or steaming (20 minutes at 80°C). Slides were then incubated at room temperature with antibodies directed against glial fibrillary acidic protein (GFAP) (polyclonal, 1:6000; Dako Corp., Carpinteria, CA, USA), S-100 protein (polyclonal, 1:6000; Dako), synaptophysin (monoclonal, 1:50; Boehringer Mannheim, Mannheim, Germany), chromogranin (monoclonal, prediluted; Ventana Medical Systems, Tucson, AZ, USA), neurofilament protein (SMR311; monoclonal cocktail 1:1000; Sternberger Monoclonal Inc., Lutherville, MD, USA), and MIB1 (monoclonal, 1:150; Immunotech, Inc, Westbrook, ME, USA). Antibodies were detected using the avidin-biotin complex (ABC) method, with diaminobenzidine as the chromogen. Quantitating the percentage of nuclei staining with MIB1, an antibody directed against the nuclear antigen Ki67, involved triplicate, manual counting of at least 500 tumor cells in the areas of maximal nuclear staining. A mean percentage of positively stained nuclei was calculated.
Clinicopathologic Correlation
Several parameters, including extent of surgical resection, the use of postoperative radiation therapy, histopathologic features, and proliferation indices (mitotic rate and MIB1 index) were studied in relation to tumor recurrence and patient survival.
RESULTS
Clinical and Radiographic Features
Clinical and radiologic features are listed in Table 1 . Tumors occurred in 18 male and 17 female patients ranging in age from 5 to 76 years (median 34 years). Presenting symptoms included seizures, diplopia, headache, and vomiting. Tumors affected the frontal (46%), parietal (23%), temporal (14%), occipital (11%), thalamic (3%), or hypothalamic (3%) regions. Radiologically, EVNs were solitary, variably enhancing masses, often with cystic components (57%) (Fig. 1) .
Pathologic Features
Microscopically, EVNs were solid lesions composed of neurocytic tumor cells arranged in sheets, clusters, ribbons, or rosettes, with neuropil dispersed either in broad zones (neuropil islands), between these cell arrangements, or localized within the rosettes (Table 2 ; Fig. 2 ). The solid pattern, which exhibited sheet-like growth with sparse intercellular neuropil, was most common (83%). Cell clusters with intervening neuropil islands were noted in 71%, the neuropil often being perivascular in orientation and resulting in a superficial resemblance to ependymoma. More than one architectural pattern was seen in most tumors.
Neurocytes most often demonstrated finely granular, slightly eosinophilic cytoplasm. Less often they exhibited cytoplasmic clearing, which, in combination with round nuclei, suggested a diagnosis of oligodendroglioma. A defining feature of neurocytomas was strong, diffuse synaptophysin immunoreactivity both within the cytoplasm and in the neuropil. Although tumors with histologic evidence of astrocytic differentiation were not included in the study, we noted focal GFAP reactivity in tumor cells with neurocytic features in almost half of the cases (46%). Ganglion cell differentiation was seen in 66% of EVNs, either focally (29%) or diffusely (37%). In three cases compact nodules of ganglion cells emerged from a neurocytic background. Faint cytoplasmic chromogranin reactivity was noted within the gan- glion cell cytoplasm but was not a typical feature of neurocytoma cells. Nuclei of the neurocytic component were striking in terms of their monotony at low magnification. They were most often round with finely speckled chromatin patterns, distinct nuclear rims, and 1-3 small nucleoli (Fig.  3) . Mitotic rates were generally low, 23 tumors having indices of 0-1 mitoses/10 HPF. Nine tumors exhibited Ն3 mitoses/10 HPF, the highest rate being 9 mitoses/10 HPF. MIB1 indices generally correlated with mitotic rates and varied from 1% to 18%. Fifty-five percent of tumors studied had MIB1 indices <2%.
In most EVNs the interface with adjacent brain was well defined, tumor borders being pushing rather than infiltrative in nature (Fig. 4) . In eight cases the tumor borders were not as well defined; the cells infiltrated adjacent brain singly or in small clusters, but not widely. Immunohistochemical stains for GFAP and neurofilament protein highlighted the pushing and/or focally entrapping tumor borders. Reactive, GFAP-positive astrocytes were seen in peritumoral brain tissue and within the periphery of the tumors. This pattern of immunoreactivity mirrored that seen on neurofilament protein stains, in which entrapped, intratumoral axons lay in parallel to those in surrounding brain.
Grading
Our initial slide review indicated that extraventricular neurocytic neoplasms represent a spectrum with regard to circumscription, architecture, cellularity, and proliferation rates. Some were clearly well differentiated, whereas others showed one or more of the "atypical" histologic features associated with aggressive behavior in central neurocytoma as well as other central nervous system tumors. These included vascular proliferation, necrosis, and increased mitotic activity (rate Ն3 mitoses/10 HPF) (Fig. 5) . Eleven EVNs were designated "atypical" based on finding geographic necrosis, vascular proliferation, or increased mitotic activity (Ն3 mitoses/10 HPF). MIB1 proliferation indices of >5% indicated increased proliferation and supported the designation of "atypical" but were not used as an independent parameter. Mitotic indices in histologically atypical EVNs ranged from 2 to 9 mitoses/10 HPF, whereas MIB1 indices ranged from 3% to 18%. Nine tumors had mitotic rates Ն3 mitoses/10 HPF. Six of 11 atypical EVNs exhibited vascular proliferation and six showed necrosis; both features were present in five cases. Ganglion cells were noted in 73% of the atypical tumors.
Twenty-four lesions were classified as welldifferentiated EVNs. All architectural patterns were seen in these tumors, ganglion cells being a feature in 63% and focal GFAP staining in 48% of the tumors so stained. Mitotic indices ranged from 0 to 2 mitoses/10 HPF. MIB1 indices varied from 1% to 4% (mean 1.8%). Neither vascular proliferation nor geographic necrosis was encountered in well-differentiated tumors.
Treatment and Follow-up
Nineteen tumors were biopsied or subtotally resected, whereas 14 were gross totally resected. Extent of resection was unknown in two cases. Seventeen patients underwent radiation therapy (mean dose 55 Gy), three after
FIG. 2. Histopathologic features of EVNs. Neurocytomas consisted of a monotonous population of tumor cells that had round regular nuclei and a fine neuropil matrix. Tumor cells were most often found in sheets (A) or in cell clusters with neuropil islands (B). Less frequent architectural patterns include linear arrays (C), neurocytic rosettes (D), and ribbons (E). Ganglion cell differentiation was seen in the majority of EVNs (F). EVNs were all strongly and diffusely immunoreactive for synaptophysin (G). Chromogranin immunoreactivity highlighted neoplastic ganglion cells but not neurocytic tumor cells (H).
GTR and 14 after STR. Of the latter, two were first irradiated upon tumor recurrence. Among the 30 cases with available follow-up, 10 tumors recurred. Of these, three patients died of disease progression. Seven patients with recurrent tumors are alive with disease at the most recent follow-up (mean 38 months). The remaining 20 tumors did not recur after initial resection.
Among the 14 patients treated by GTR, follow-up data were available in 11. None of their tumors recurred (mean follow-up 29 months). Among the 19 tumors treated by STR, 10 recurred (median interval 17 months); of these, three caused death (6, 14, and 43 months after initial presentation). The remaining nine tumors treated by STR did not recur.
Clinicopathologic Correlation
A GTR was achieved in 57% of well-differentiated EVNs. Five of 20 well-differentiated tumors recurred (25%), each after STR (6, 20, 48, 60 , and 72 months). Gross total resection was achieved in only 10% of atypical EVNs. Five of 10 atypical EVNs recurred (50%), each after STR at 6, 10, 14, 18, and 43 months.
All 10 tumors that recurred in the present study were treated by STR ( Table 3 ). EVNs that recurred after STR occurred in older patients (mean age 53 years) than those that did not recur (mean age 27 years). Six of the 10 tumors subject to biopsy or STR that went on to recur were treated with radiation after initial resection; six of nine STR tumors that did not recur were treated by radiation after initial resection. Five of the 10 EVNs that eventually recurred were "atypical," and seven of nine tumors (77%) had MIB1 proliferation indices Ն5%. Among the nine EVNs that did not recur after STR, four (44%) demonstrated atypical histologic features and three of six tumors had MIB1 indices Ն5%. The MIB1 proliferation indices were significantly higher in those STR EVNs that eventually recurred (mean 9.4%) than those that did not (mean 6.2%, p <0.05).
The three EVNs that resulted in death occurred in patients that were 67, 68, and 71 years of age. Two had been STR and one biopsied; all had been irradiated. All three also exhibited atypical histologic features. Their mean MIB1 labeling index was 8.8%.
DISCUSSION
Neurocytic neoplasms that arise within central nervous system parenchyma share key histologic features with the more common central neurocytoma but exhibit a wider morphologic spectrum. Their defining histologic feature is their composition of monotonous neoplastic cells with round, regular nuclei embedded in a matrix of fine neuronal processes (neuropil). Neurocytes are typically disposed in a sheet-like pattern or in clusters separated by islands of neuropil. Less commonly, the tumors appear more structured, featuring ribbons or neurocytic rosettes. The processes composing the neoplastic neuropil of EVNs are much finer than glial processes, thus assuming a "velvety" appearance that serves as an aid to differentiate diagnosis. Neurocytomas of both intraventricular and extraventricular type can be readily misinterpreted as ependymoma in that the perivascular disposition of neuropil in neurocytomas yields a superficial resemblance.
Of interest was the high degree of ganglionic differentiation noted in EVN. More than 60% showed either a focal or diffuse distribution of ganglion cells. Nodules of such cells were present in occasional instances. The incidence of ganglion cell differentiation in EVN appears far higher than in central neurocytoma. 7, 8, 28, 33, 39 Söylemezoglu et al. 33 and von Deimling et al. 39 identified ganglion cells in two of 36 and in one of 11 central neurocytomas, respectively. Figarella-Branger et al. found none among 20 central neurocytomas. 7 It is of note that this manifestation of advanced differentiation failed to correlate with cell proliferation, the presence of atypical histologic features, or tumor recurrence in the present series.
Immunohistochemical features of glial differentiation are also more frequent in EVNs. Although the present study excluded tumors exhibiting overt astrocytic differentiation, after discounting GFAP immunoreactivity in entrapped non-neoplastic astrocytes at the tumor's periphery, we found focal cytoplasmic GFAP staining in tumor cells with neurocytic features that also demonstrated synaptophysin immunoreactivity. Immunoreactivity for GFAP, a feature of nearly half of EVNs, occurred as often in well-differentiated as atypical tumors and did not correlate with recurrence.
FIG. 3.
Nuclei of EVN were typically round and regular. The finely speckled chromatin patterns, distinct nuclear rims, and 1-3 small nucleoli were well seen in cytologic smear preparation (A) and hematoxylin and eosin sections (B).
Due in part to immunohistochemical evidence of neuronal and glial differentiation in neurocytic neoplasms, some have suggested the term "ganglioglioneurocytoma" be applied to EVNs exhibiting both, and the designation "ganglioneurocytoma" to EVNs showing neurocytic and ganglionic differentiation. 9, 22 Neither GFAP expression nor ganglionic differentiation appears to correlate with tumor behavior, however. Less frequent forms of differentiation, including smooth muscular, lipomatous, and melanocytic, have also been noted in central neurocytomas and EVNs. 4, 14, 24, 25 It is not known if these rare forms of differentiation are of clinical significance.
With regard to biologic behavior, our study indicated that approximately one third of EVNs recurred within the relatively short period of follow-up. Importantly, no totally resected EVN recurred, whereas just over half of subtotally resected tumors did so. Thus, extent of resection appears to be a key determinant of recurrence. Admittedly, we found a higher ratio of well-differentiated to atypical EVNs in the total resection subgroup.
Because a slight majority of subtotally resected EVNs recurred, we sought clinical and pathologic features associated with recurrence in this subset. It is of note that those EVNs recurring after STR presented in an older patient group (mean age 53 years) than those that did not (mean age 27 years). As a group, recurring tumors subject to STR were as often treated by radiation therapy as tumors that did not recur. In addition, MIB1 labeling indices were significantly higher in STR EVNs that eventually recurred, more often having indices Ն5%. Nevertheless, the proportion of EVNs exhibiting histologic atypia was only slightly higher in the subgroup of STR tumors that subsequently recurred. Given the relatively small number of recurrent tumors, it is difficult to state which feature best correlated with recurrence. In any event, extent of resection appeared the dominant factor. We believe the cellular proliferation and histologic features of atypia are the bases of aggressive tumor growth, thereby affecting their resectability. Indeed, in those subtotally resected tumors that recurred, high proliferation rates were a frequent feature. As previously noted, these more biologically aggressive tumors affected older patients.
Because neurocytomas most often occur within the lateral ventricles, neurocytic neoplasms are not always considered in the differential diagnosis of intraparenchymal cerebral tumors. At both sites the main alternative A potentially complicating feature of EVN is the frequent finding of focal GFAP immunoreactivity in neurocytic tumor cells as well as staining of entrapped nonneoplastic astrocytes. The latter are most frequently seen at the periphery of EVN in a distribution similar to that of the entrapped axons seen by neurofilament protein immunostains. The significance of GFAP reactivity in tumor cells is difficult to explain, but in vitro experiments with neurocytomas have shown a shift from synaptophysin to GFAP expression with cell passages. 41 Western blots of central neurocytomas have demonstrated GFAP in the same tumors that failed to show GFAP staining by immunohistochemistry, suggesting a limited degree of glial differentiation. 40 It is also of note that the oligodendrocyte-like cells of dysembryoplastic neuroepithelial tumor exhibit not only a similar mixed immunophenotype but divergent glial and neuronal differentiation at the ultrastructural level as well. 13 In some instances ultrastructural studies are necessary to demonstrate unequivocal neuronal features in EVN. 11, 26 These typically reveal a dense neuropil between tumor nuclei consisting of microtubule-containing processes, dense core granules and vesicles, and occasional synapses.
The diagnosis of EVN is aided by radiologic features that depict a circumscribed rather than a diffusely infiltrating mass. EVNs are also likely to be contrastenhancing and/or cystic. Their radiographic appearance suggests a low-grade lesion, e.g., pilocytic astrocytoma, pleomorphic xanthoastrocytoma, and ganglioglioma.
Although neurocytomas are best known for their central location, they occur throughout the neuroaxis. In addition to extraventricular examples arising in the cerebral hemispheres and intraventricular sites distant from the region of the foramen of Monro, neurocytic tumors also occur in the cerebellum, midbrain, and spinal cord. [3] [4] [5] 32, [34] [35] [36] Like central neurocytoma, most EVNs are well differentiated and do not recur, especially after complete resection. Subtotal resection, high proliferation rates, atypical histologic features, and older patient age appear to be associated with an increased likelihood of recurrence.
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